Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Where are we now with CBD and other questions facing dermatology? Perspectives from Adam Friedman, MD

Where are we now with CBD and other questions facing dermatology? Perspectives from Adam Friedman, MD

FromDerms and Conditions


Where are we now with CBD and other questions facing dermatology? Perspectives from Adam Friedman, MD

FromDerms and Conditions

ratings:
Length:
23 minutes
Released:
Jul 8, 2021
Format:
Podcast episode

Description

In Episode 7 of Derms and Conditions, our host James Del Rosso, DO talks with Adam Friedman, MD, Professor and Chair of Dermatology at The George Washington University School of Medicine & Health Sciences on the use of topical CBD in dermatology and the use of oral spironolactone in breast cancer patients. 
Dr. Del Rosso and Dr. Friedman discuss many diverse topics on CBD including FDA regulations, counseling patients, and clinical studies on topical CBD gel in the treatment of xerosis and atopic dermatitis. They further discuss evidence regarding the risk of oral spironolactone in breast cancer recurrence along with effective ways to manage and counsel patients who have a personal or family history of breast cancer. 
Released:
Jul 8, 2021
Format:
Podcast episode

Titles in the series (79)

Now in Season 2, Derms and Conditions is a podcast from the team that brings you the Fall Clinical and Winter Clinical Dermatology Conferences. Each episode, you'll hear from leading Dermatologists in the US as they talk about Dermatology's hottest and most relevant topics and conditions. Dermatologists all face a barrage of new information virtually every day that is difficult to keep up with and digest. In this podcast, you'll hear about clinical practice tips and treatment pearls that you can implement on a daily basis in your busy practice. Subscribe to Derms and Conditions today to stay in-the-know with the country's leading experts. Thanks for listening!